All studies
RecruitingPHASE2INTERVENTIONAL

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

This study, called KORTUC Phase II, is looking at a new way to treat locally advanced or returning breast cancer. It tests whether a simple gel containing a very diluted form of hydrogen peroxide can help standard radiotherapy shrink large breast cancer lumps more effectively. The special gel, called 'KORTUC', is injected directly into the cancer twice a week while you receive radiotherapy. Early research and small studies in Japan have shown that this approach might significantly improve how well radiotherapy works, potentially causing cancer lumps to shrink completely in many cases. The main side effect reported so far is mild discomfort at the injection site. This trial aims to further investigate its safety and effectiveness.

At a glance

Status
Recruiting
Phase
PHASE2
Sponsor
Institute of Cancer Research, United Kingdom
Enrolment target
184
Start
16 Jun 2020
Estimated completion
30 Jun 2028

What is this study about?

This study is exploring an exciting new approach for people with breast cancer that is either locally advanced (meaning it's grown into nearby tissues) or has returned in the same area. The main idea is to make standard radiotherapy treatment work even better. Radiotherapy uses high-energy rays to kill cancer cells, but sometimes larger lumps can be harder to treat effectively with radiotherapy alone.

The study uses a common, inexpensive chemical called hydrogen peroxide, but in a very dilute (weak) form, mixed into a special gel. We inject this gel directly into the cancer lump. The aim is for the hydrogen peroxide to act as a "sensitiser," which means it helps the cancer cells become more sensitive to the radiotherapy. This could mean that the radiotherapy becomes much more powerful at shrinking and getting rid of the cancer, without needing to increase the dose of radiotherapy itself.

This method has already been tested in Japan, and the results have been very encouraging. Researchers there reported that in many cases, large breast cancers treated this way completely disappeared. The main side effect noted was some mild to moderate discomfort where the injection was given, lasting up to 24 hours. This UK trial is an important next step to confirm these promising findings and make sure the treatment is safe and works well for more people.

Key takeaways

  • Tests a new gel to make radiotherapy more effective for breast cancer.
  • Uses a very diluted form of hydrogen peroxide injected into the tumour.
  • Early results from Japan showed promising shrinkage of large tumours.
  • Main reported side effect is mild, short-term discomfort at injection site.
  • Aims to confirm safety and effectiveness for UK patients.

Who may be eligible?

To join this study, you must be 18 years or older. You should have breast cancer that is locally advanced or has come back in the local area, and your doctor thinks you need radiotherapy to control it. The cancer lump needs to be big enough to measure (at least 3cm) but not too big (no more than 15cm) and in a place where it's safe to give injections. You should also be generally well enough for radiotherapy and expected to live for at least 12 months.

There are also some reasons why you might not be able to join. For example, if you've already had radiotherapy to the area being studied, or if your cancer is in a spot that's too close to important blood vessels or nerves, you might not be able to take part. This study also can't be for you if you're pregnant or breastfeeding, or if you're allergic to any of the ingredients in the special gel. Most other cancer treatments will need to have stopped at least three weeks before starting, but some specific treatments like Herceptin, Pertuzumab, Denosumab, hormone therapies, and bisphosphonates are allowed.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Do you have locally advanced or recurrent breast cancer?
  3. Is your cancer lump at least 3cm but no more than 15cm across?
  4. Do you need radiotherapy for your cancer?
  5. Are you able to attend regular appointments for injections and radiotherapy?
  6. Are you not currently pregnant or breastfeeding?
Answer every question to see your result.

What does participation involve?

If you decide to take part, you will receive injections of the special hydrogen peroxide gel directly into your cancer lump. A specialist doctor or trained nurse will give these injections twice a week, throughout your 3-week course of standard radiotherapy. They'll use an ultrasound machine to make sure the injection goes into the right spot, and your skin will be numbed with a local anaesthetic first. Each injection takes about 10-15 minutes. The gel is designed to release the hydrogen peroxide slowly over two days.

Throughout the study, you'll have regular check-ups and scans to see how the treatment is working and to monitor any side effects. You'll be asked to come for appointments that match your radiotherapy schedule. The total time you'd be actively involved in the treatment part of the study is about three weeks, during your radiotherapy. There will also be follow-up appointments to track your progress after treatment has finished. You'll be given all the details about your specific schedule if you're considering joining.

Potential risks and benefits

Participating in this study could potentially offer a new and more effective way to treat your breast cancer, especially if it's large or has returned. The main potential benefit is that the hydrogen peroxide gel might make your radiotherapy much more successful at shrinking or eliminating the cancer. However, as with any medical treatment, there are potential risks. The most common side effect expected is mild to moderate discomfort or pain at the injection site, which usually lasts less than 24 hours. There could also be other unexpected side effects. You have the right to withdraw from the study at any time, for any reason, without it affecting your future medical care.

Locations (10)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Regional Cancer Centre (RCC)
    Verified postcode
    Trivandrum, India· Recruiting
  • Christian Medical Centre
    Verified postcode
    Vellore, India· Recruiting
  • Tata Medical Centre
    Verified postcode
    Kolkata, India· Recruiting
  • Tata Memorial Centre
    Verified postcode
    Mumbai, India· Recruiting
  • Royal Cornwall Hospitals NHS Trust
    Verified postcode
    Truro, United Kingdom· Recruiting
  • Beatson West of Scotland Cancer Centre
    Verified postcode
    Glasgow, United Kingdom· Recruiting
  • Cambridge University Hospitals NHS Foundation Trust
    Verified postcode
    Cambridge, United Kingdom· Recruiting
  • The Christie NHS Foundation Trust
    Verified postcode
    Manchester, United Kingdom· Recruiting
  • University Hospitals of North Midlands NHS Trust
    Verified postcode
    Stoke-on-Trent, United Kingdom· Recruiting
  • The Royal Marsden NHS Foundation Trust
    Verified postcode
    Sutton, United Kingdom· Recruiting

Common questions

What is hydrogen peroxide and is it safe?

Hydrogen peroxide is a common chemical. In this study, we use a very weak, diluted form that's injected directly into the cancer to make radiotherapy work better. Early studies suggest it's safe at this low concentration when used this way.

Will the injections hurt?

Before the injection, your skin will be numbed with local anaesthetic. Some people in earlier studies reported mild to moderate discomfort or pain at the injection site afterwards, usually lasting less than 24 hours.

How long does the treatment take?

The injections happen twice a week for three weeks, matching your standard radiotherapy schedule. Each injection takes about 10-15 minutes. You'll also have follow-up appointments after treatment.

What kind of breast cancer is this for?

This study is for people with breast cancer that is locally advanced (has grown into nearby tissues) or has come back in the local area, especially if the cancer lump is large.

Can I still have other treatments if I join?

Some other cancer treatments might need to stop before you start this study, but specific ones like Herceptin, Pertuzumab, Denosumab, hormone therapies, and bisphosphonates are usually allowed.

How to find out more

Lone Gothard

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Pat…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.